Implication of p16 Promoter Methylation, the BRAFV600E Mutation, and ETS1 Expression Determination on Papillary Thyroid Carcinoma Prognosis and High-Risk Patients’ Selection
- DOI
- 10.3390/biomedicines13071583
- Published
- 2025-06-27
- Container
- Biomedicines
- Publisher
- MDPI AG
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3390/biomedicines13071583,
title = {Implication of p16 Promoter Methylation, the BRAFV600E Mutation, and ETS1 Expression Determination on Papillary Thyroid Carcinoma Prognosis and High-Risk Patients’ Selection},
author = {Stefana Stojanović Novković and Sonja Šelemetjev and Milena Krajnović and Ana Božović and Bojana Kožik and Uršula Prosenc Zmrzljak and Tijana Išić Denčić},
year = {2025},
journal = {Biomedicines},
doi = {10.3390/biomedicines13071583},
url = {https://doi.org/10.3390/biomedicines13071583}
}RIS
TY - JOUR TI - Implication of p16 Promoter Methylation, the BRAFV600E Mutation, and ETS1 Expression Determination on Papillary Thyroid Carcinoma Prognosis and High-Risk Patients’ Selection AU - Stefana Stojanović Novković AU - Sonja Šelemetjev AU - Milena Krajnović AU - Ana Božović AU - Bojana Kožik AU - Uršula Prosenc Zmrzljak AU - Tijana Išić Denčić PY - 2025 JO - Biomedicines DO - 10.3390/biomedicines13071583 UR - https://doi.org/10.3390/biomedicines13071583 ER -
APA
Novković, S. S., Šelemetjev, S., Krajnović, M., Božović, A., Kožik, B., Zmrzljak, U. P., & Denčić, T. I. (2025). Implication of p16 Promoter Methylation, the BRAFV600E Mutation, and ETS1 Expression Determination on Papillary Thyroid Carcinoma Prognosis and High-Risk Patients’ Selection. Biomedicines. https://doi.org/10.3390/biomedicines13071583
Source records
- crossref · retrieved 2026-09-26T20:06:19.994Z